Enveric Biosciences Inc vs Suncor Energy Inc. — how do they compare? Enveric Biosciences Inc trades at $1.36 (market cap $5.32M), while Suncor Energy Inc. trades at $61.09 (market cap $70.89B). The key difference: Suncor Energy Inc. is far larger — about 13325.2× Enveric Biosciences Inc's market cap, and Suncor Energy Inc. pays a 2.78% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | SU | |
|---|---|---|
Market Cap | $5.32M | $70.89B |
Sector | Health | Energy |
52-Week High | $17.40 | $69.73 |
52-Week Low | $1.28 | $38.17 |
Enterprise Value | $408.82K | $79.02B |
Dividend Yield | — | 2.78% |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
Suncor Energy (SU) trades at $61.04, down 0.38% on the day, with a bullish technical signal supported by moving averages. The company maintains solid fundamentals with a P/E of 16.37, net income margin of 11.62%, and consistent positive cash flow from operations ($12.78B in 2025). Recent quarterly earnings show a mixed pattern, beating expectations in Q3 and Q4 2025 but missing in Q1 2026, while Q2 2026 results are pending. The stock offers a dividend yield with a recent $0.60 per share payment announced for June 2026.
SU presents a compelling value opportunity with attractive valuation metrics (EV/EBITDA 6.91) and strong analyst support (74% buy ratings). Key opportunities include operational improvements, record production levels, and shareholder returns through dividends. Primary risks involve commodity price volatility, recent operational incidents like the Sarnia refinery fire, and broader energy sector headwinds from potential oil price declines and recession concerns.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →